{"text": ["Overconfident", "Predictions", "for", "Stocks,", "the", "Election,", "and", "a", "Covid-19", "Vaccine"], "created_at": "2020-10-30 22:18:00"}
{"text": ["Date", "Is", "Set", "for", "Merger", "Between", "Mylan", "and", "Pfizer's", "Upjohn", "Unit"], "created_at": "2020-10-30 19:39:00"}
{"text": ["U.K.", "regulator", "is", "accelerating", "reviews", "of", "COVID-19", "vaccines", "from", "Pfizer", "and", "AstraZeneca,", "according", "to", "a", "report"], "created_at": "2020-10-30 19:13:00"}
{"text": ["Mylan", "and", "Pfizer", "Receive", "Clearance", "from", "the", "U.S.", "Federal", "Trade", "Commission", "for", "Proposed", "Combination", "of", "Mylan", "and", "Upjohn"], "created_at": "2020-10-30 17:39:00"}
{"text": ["How", "Novavax", "Has", "a", "2-Pronged", "Approach", "to", "Vaccine", "Sales"], "created_at": "2020-10-30 17:38:38"}
{"text": ["Pharma", "Stock", "Roundup:", "Q3", "Earnings,", "Resumption", "of", "AZN/JNJ", "Coronavirus", "Vaccine", "Study"], "created_at": "2020-10-30 17:06:05"}
{"text": ["Novavax", "lays", "out", "specific", "minority", "targets", "for", "U.S.", "COVID-19", "vaccine", "trial"], "created_at": "2020-10-30 17:01:30"}
{"text": ["U.S.", "approves", "combination", "of", "Pfizer's", "Upjohn", "and", "Mylan"], "created_at": "2020-10-30 16:27:25"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "UnitedHealth", "Group,", "Adobe,", "Pfizer,", "Intel", "and", "T-Mobile", "US"], "created_at": "2020-10-30 15:08:03"}
{"text": ["UK", "starts", "accelerated", "reviews", "for", "COVID-19", "vaccines", "from", "AstraZeneca", "and", "Pfizer", "-", "Bloomberg"], "created_at": "2020-10-30 11:25:38"}
{"text": ["What's", "the", "Outlook", "for", "BioNTech", "Stock?"], "created_at": "2020-10-30 10:31:00"}
{"text": ["What's", "the", "Outlook", "for", "BioNTech", "Stock?"], "created_at": "2020-10-30 10:31:00"}
